|
|
| | Methanone, (4-amino-7-fluoroimidazo[1,5-a]quinoxalin-8-yl)[(3R,5S)-3-methyl-5-[4-(trifluoromethyl)phenyl]-4-morpholinyl]- Basic information |
| | Methanone, (4-amino-7-fluoroimidazo[1,5-a]quinoxalin-8-yl)[(3R,5S)-3-methyl-5-[4-(trifluoromethyl)phenyl]-4-morpholinyl]- Chemical Properties |
| density | 1.53±0.1 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted) | | pka | 5.07±0.40(predicted) |
| | Methanone, (4-amino-7-fluoroimidazo[1,5-a]quinoxalin-8-yl)[(3R,5S)-3-methyl-5-[4-(trifluoromethyl)phenyl]-4-morpholinyl]- Usage And Synthesis |
| Uses | PRMT5-IN-44 (compound 12) is a PRMT5 inhibitor. PRMT5-IN-44 can be used in cancer research[1]. | | IC 50 | PRMT5 | | References | [1] Yao Bing, et al. Novel prmt5 inhibitor and use thereof.WO2024067445A1 |
| | Methanone, (4-amino-7-fluoroimidazo[1,5-a]quinoxalin-8-yl)[(3R,5S)-3-methyl-5-[4-(trifluoromethyl)phenyl]-4-morpholinyl]- Preparation Products And Raw materials |
|